Cancer-associated retinopathy and its clinical features Kanser ilişkili retinopati ve klinik özellikleri

AYHAN Z., ÜNLÜ B., Seymenoǧlu G., SAATCİ A. O.

Retina-Vitreus, vol.26, no.1, pp.68-71, 2017 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 1
  • Publication Date: 2017
  • Journal Name: Retina-Vitreus
  • Journal Indexes: Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.68-71
  • Keywords: Cancer-associated retinopathy, Nyctalopia, Retinopathy, Visual loss
  • Dokuz Eylül University Affiliated: Yes


Purpose: To report the clinical features of a case with cancer-related retinopathy and review the disease. Method: Retrospective case report. Results: A 65-year-old woman was presented to us with a history of bilateral gradual vision deterioration and nyctalopia for three months'duration. She was previously diagnosed to have a neuroendocrine tumor in 2008 and received a multitude of systemic therapies including surgical resection, chemotherapy and radiotherapy. On examination, her best-corrected visual acuity was 0.3 with normal anterior segment and normal looking posterior pole OU. Bilateral peripheral consantric narrowing was present at the visual field test and depressed scotopic responses was revealed at the ERG test. The diagnosis was cancer-associated retinopathy. Unfortunately, she died in three months time due to multiple metastasis. Conclusion: Cancer-associated retinopathy should be considered in differential diagnosis of patients presenting with progressive vision loss and nyctalopia.